TGF-β3: a potential biological therapy for enhancing chondrogenesis

QO Tang, K Shakib, M Heliotis, E Tsiridis… - … on Biological Therapy, 2009 - Taylor & Francis
effects of TGF-β3 on cartilage regeneration. Results/conclusion: There is robust in vitro evidence
suggesting a positive dose- and time-dependant effect of TGF-β3TGF-β3 cultured with …

TGF-β3: A promising growth factor in engineered organogenesis

J Hao, RR Varshney, DA Wang - … opinion on biological therapy, 2008 - Taylor & Francis
TGF-β3 for organogenesis with engineering methodology and a regenerative medical
perspective. Results/conclusion: TGF-β3 … broad and important effects of TGF-β3 on organogenesis…

Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical

NL Occleston, HG Laverty, S O'Kane… - Journal of Biomaterials …, 2008 - Taylor & Francis
… the molecular mechanisms and efficacy of scar reduction therapies between these species.
We … to evaluate the safety and efficacy of human recombinant TGFβ3 (JuvistaTM) in human …

Biological Role and Therapeutic Targeting of TGF3 in Glioblastoma

K Seystahl, A Papachristodoulou, I Burghardt… - … cancer therapeutics, 2017 - AACR
… that TGF-β 3 might function as a gatekeeper controlling downstream signaling despite high
expression of TGF-β 1 and TGF-β … the inhibitory effect on SMAD phosphorylation by TGF-β 3 -…

Targeting TGF-β signaling for therapeutic gain

RJ Akhurst - Cold Spring Harbor perspectives in biology, 2017 - cshperspectives.cshlp.org
transforming growth factor βs (TGF-βs), TGF-β1, -β2, and -β3, … , treatment of chronic fibrotic
conditions by current anti-TGF-β … a therapeutic window and dosing regimen between efficacy

TGF-β3 and cancer: A review

HG Laverty, LM Wakefield, NL Occleston… - Cytokine & growth factor …, 2009 - Elsevier
… Indeed pre-clinical data showing the suppressor effects of TGF-β3 in the early stages of
tumourigenesis, coupled with the acute, low doses applied and the low systemic bioavailability …

TGF-β3 in the treatment of pressure ulcers: a preliminary report

J Hirshberg, J Coleman, B Marchant… - Advances in skin & …, 2001 - journals.lww.com
… One subject discontinued because of an unsatisfactory therapeutic effect and another
discontinued because of aspiration pneumonia. Despite these dropouts, all 14 patients were in the …

Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a Smad3 …

TV Do, LA Kubba, H Du, CD Sturgis… - Molecular cancer research, 2008 - AACR
… We further investigated the effects of TGF-β1, TGF-β2, and TGF-β3 on the epithelial markers,
E-cadherin and occludin, and the mesenchymal markers, vimentin and N-cadherin, by …

TGF-β inhibitors for the treatment of cancer

M Lahn, S Kloeker, BS Berry - Expert opinion on investigational …, 2005 - Taylor & Francis
… Taken together, the direct effects of TGF-β on tumour cells and its indirect effects on tumour
… In humans, three distinct isoforms of TGF-β (TGF-β1, -β2 and -β3) have been identified, all …

[HTML][HTML] Targeting TGFβ signal transduction for cancer therapy

S Liu, J Ren, P Ten Dijke - Signal transduction and targeted therapy, 2021 - nature.com
treatment, and provide perspectives of combined treatment to overcome chemo/targeted/radio-therapy
resistance and increase the efficiency … and after treatment with 5 ng/ml TGFβ3 for …